| 张丽娜,李田园,郭立新,潘琦.持续葡萄糖监测临床应用进展及未来前景[J].中国临床保健杂志,2022,25(3):303-309. |
| 持续葡萄糖监测临床应用进展及未来前景 |
| Clinical application progress and future prospects of continuous glucose monitoring |
| 投稿时间：2022-04-18 |
| DOI：10.3969/J.issn.1672-6790.2022.03.003 |
| 中文关键词: 糖尿病 持续葡萄糖监测 血糖控制 |
| 英文关键词: Diabetes mellitus Continuous glucose monitoring Glycemic control 〖FL |
| 基金项目:国家重点研发计划项目(2020YFC2009006) |
|
| 摘要点击次数: 1425 |
| 全文下载次数: 2720 |
| 中文摘要: |
| 血糖监测是糖尿病管理中的主要手段之一,不断发展的持续葡萄糖监测(CGM)技术为临床提供了连续、全面、可靠的血糖信息,是传统血糖监测的有效补充。由CGM衍生出一系列血糖控制的新指标,如目标范围内时间等与糖尿病微血管并发症、大血管并发症以及妊娠结局显著相关。为规范CGM的临床应用,2021年中华医学会糖尿病学分会及2022年美国糖尿病学会分别发布指南。CGM技术的创新和发展提高了糖尿病及其慢性并发症的管理水平。 |
| 英文摘要: |
| Blood glucose monitoring is one of the main tools in diabetes management.The development of continuous glucose monitoring (CGM) technology provides continuous,comprehensive and more reliable blood glucose information for clinical practice,and is an effective supplement to traditional blood glucose monitoring.A series of new indicators of glycemic control derived from CGM,such as time in range (TIR),are significantly associated with diabetic microvascular complications,macrovascular complications and pregnancy outcomes.In order to standardize the clinical application of CGM,the Chinese Diabetes Society (CDS) in 2021 and the American Diabetes Association (ADA) in 2022 have issued guidelines respectively.Innovations and developments in CGM technology have improved the management of diabetes and its chronic complications. |
|
查看全文
|
| 关闭 |
|
|
|